0001562180-23-008571.txt : 20231228 0001562180-23-008571.hdr.sgml : 20231228 20231228163837 ACCESSION NUMBER: 0001562180-23-008571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231226 FILED AS OF DATE: 20231228 DATE AS OF CHANGE: 20231228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russell Alan J CENTRAL INDEX KEY: 0001853529 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40236 FILM NUMBER: 231523116 MAIL ADDRESS: STREET 1: 3415 COLORADO AVE CITY: BOULDER STATE: CO ZIP: 80303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edgewise Therapeutics, Inc. CENTRAL INDEX KEY: 0001710072 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821725586 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 720-262-7002 MAIL ADDRESS: STREET 1: 1715 38TH ST CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2023-12-26 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001853529 Russell Alan J C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 true true false false Chief Scientific Officer false Common Stock 2023-12-26 4 S false 172585.00 9.3293 D 3606.00 D This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price. /s/ John R. Moore, Attorney-in-Fact for Russell Alan J 2023-12-28